MedComm - Oncology is a peer-reviewed, multidisciplinary, online open access journal that publishes the high-impact clinical, basic and translational advances in all aspects of oncology, emphasizing on disclosing the molecular pathogenic mechanism of human cancer and suggesting new techniques for cancer diagnosis and therapy.
MedComm - Oncology provides a home for the clinical and experimental advances on solving clinical and scientific issues of cancer, concerning all aspects of cancer research, such as oncogenic mechanism, early screening/prevention, precise diagnosis and targeted therapy. MedComm - Oncology is also a multidisciplinary journal, covering disciplines including but not limited to clinical medicine, genetics, bioinformatics, molecular biology, cell biology, biological chemistry, pharmacology, medicinal chemistry and pharmacy. Researchers in these fields are welcome to submit their valuable work to MedComm - Oncology.
Topics of interest include, but are not limited to: